Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsors

Description

As set out in paragraph C.05.010(b) of the Food and Drug Regulations (FDR), clinical trials must follow certain requirements of the protocol. Health Canada authorizes this protocol and the Research Ethics Board approves it. During the pandemic, there may be more deviations from the established protocol.

Resources

Name Format Description Link
Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsors HTML Open resource
Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsors HTML Open resource

Tags

Topics

Categories